Menopause and aging, quality of life and sexuality

Climacteric

Volumn 10, Issue 2, 2007, Pages 88-96

  Genazzani, A R ^a   Gambacciani, M ^b   Simoncini, T ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

19 NORSTEROID; 3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ALENDRONIC ACID; ANDROGEN; ANTIHYPERTENSIVE AGENT; AROMATASE INHIBITOR; BETA ENDORPHIN; BISPHOSPHONIC ACID DERIVATIVE; DESOGESTREL; DROSPIRENONE; ESTRADIOL; ESTROGEN; GESTODENE; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NEUROSTEROID; NORGESTIMATE; PARATHYROID HORMONE[1-34]; PHOSPHODIESTERASE V INHIBITOR; PROGESTERONE; RISEDRONIC ACID; STRONTIUM RANELATE; TAMOXIFEN; TESTOSTERONE; TIBOLONE;

AGING; ALZHEIMER DISEASE; AMNESIA; ANEMIA; BODY FAT DISTRIBUTION; BREAST CANCER; CARDIOVASCULAR DISEASE; CLIMACTERIUM; COLLAGEN SYNTHESIS; CONFERENCE PAPER; DEPRESSION; DISEASE ASSOCIATION; DYSPAREUNIA; ENDOMETRIAL DISEASE; ERECTILE DYSFUNCTION; FIBRINOLYSIS; GENITAL TRACT CANCER; GLUCOSE METABOLISM; HIP FRACTURE; HORMONAL THERAPY; HOT FLUSH; HUMAN; HYPERTENSION; INSULIN METABOLISM; INTERVERTEBRAL DISK; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; LIFESTYLE; MEDICAL PRACTICE; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; MENOPAUSE; METABOLIC SYNDROME X; MUSCULOSKELETAL DISEASE; NERVE CELL PLASTICITY; OBESITY; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL HEALTH; SEXUALITY; STRESS INCONTINENCE; SYMPTOM; TESTOSTERONE BLOOD LEVEL; VAGINAL DRYNESS;

AGING; BODY WEIGHT; BRAIN; CARDIOVASCULAR DISEASES; FEMALE; FEMALE UROGENITAL DISEASES; FRACTURES, BONE; HORMONE REPLACEMENT THERAPY; HUMANS; LIFE STYLE; MALE; MENOPAUSE; MENTAL HEALTH; OSTEOPOROSIS, POSTMENOPAUSAL; QUALITY OF LIFE; SEXUALITY; SKIN PHYSIOLOGY;

EID: 33947609155     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130701297760     Document Type: Conference Paper

References (37)

1. Ashraf MS, Vongpatanasin W. Estrogen and hypertension. Curr Hypertens Rep 2006;8:368-76
2. Buster JE, Kingsberg SA, Aguirre O, et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 2005;105:944-52
3. Canonico M, Oger E, Plu-Bureau G, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation 2007;115:840-5
4. Cohen LS, Soares CN, Vitonis AF, Otto MW, Harlow BL. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 2006;63:385-90
5. Cramer JA, Spilker B, eds. Quality of Life and Pharmacoeconomics in Clinical Trials - An Introduction. Philadelphia: Lippincott-Raven, 1998
6. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005;294:91-6
7. Davis SR, Goldstat R, Papalia MA, et al. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial. Menopause 2006;13:37-45
8. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med 2006;3:212-22
9. Feeny D. Preference-Based Measures: Utility and Quality-Adjusted Life Years. Oxford: Oxford University Press, 2005
10. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006;63:375-82
11. Gambacciani M, Genazzani AR. Fromthe challenge to the reassessment of the Women's Health Initiative: a personal initiative for women's health. Gynecol Endocrinol 2006;22:115-16
12. Genazzani AR, Simoncini T. Timing is everything. Gynecol Endocrinol 2007;23:1-4
13. Genazzani AR, Pluchino N, Luisi S, Luisi M. Estrogen, cognition and female ageing. Hum Reprod Update 2007;13:175-87
14. Goldstein I, Meston C, Davis S, Traish AM, eds. Women's Sexual Function and Dysfunction. Study, Diagnosis and Treatment. London: Taylor & Francis, 2005
15. Graziottin A, Leiblum SR. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopausal transition. J Sex Med 2005;2(Suppl 3):133-45
16. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993;118:622-9
17. Heinemann LAJ, Schneider HPG. Quality of life assessment in the menopause. In Eskin BA, ed. The Menopause: Endocrinologic Basis and Management Options, 5th edn. Oxford: Informa Healthcare, 2007:79-85
18. Imwalle DB, Gustafsson JA, Rissman EF. Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice. Physiol Behav 2005;84:157-63
19. Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005;26:833-76
20. Modena MG, Sismondi P, Mueck AO, et al. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits. Maturitas 2005;52:1-10
21. Nappi R. Sexuality and Menopause. Philadelphia: Elsevier, 2006
22. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl 2005;28:125-7
23. Nijland E, Davis S, Laan E, Schultz WW. Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction. J Sex Med 2006;3:763-77
24. Otte C, Hart S, Neylan TC, Marmar CR, Yaffe K, Mohr DC. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005;30:80-91
25. Ouyang P, Michos ED, Karas RH. Hormone replacement therapy and the cardiovascular system: lessons learned and unanswered questions. J Am Coll Cardiol 2006;47:1741-53
26. Panjari M, Davis SR. DHEA therapy for women: effect on sexual function and wellbeing. Hum Reprod Update 2007;Jan 5 [Epub ahead of print]
27. Revicki DA, Osoba D, Fairclough D, et al. Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Qual Life Res 2000;9:887-900
28. Schmidt PJ, Rubinow DR. Reproductive ageing, sex steroids and depression. J Br Menopause Soc 2006;12:178-85
29. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-8
30. Simon J, Braunstein G, Nachtigall L, et al. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226-33
31. Simoncini T, Mannella P, Genazzani AR. Rapid estrogen actions in the cardiovascular system. Ann N Y Acad Sci 2006;1089:424-30
32. Simoncini T, Mannella P, Fornari L, et al. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 2004;145:5745-56
33. Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven, 1996
34. Stevenson J. Menopausal Hormone Therapy. London: Taylor & Francis, 2005
35. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59-65
36. Woods NF, Carr MC, Tao EY, Taylor HJ, Mitchell ES. Increased urinary cortisol levels during the menopause transition. Menopause 2006;13:212-21
37. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab 2006;91:4335-43